Guidelines recommend different approaches to investigate for pulmonary hypertension (PH) by transthoracic echocardiography (TTE). We used data from the CIPHER study (NCT04193046) to prospectively evaluate TTE detection of PH. Participants newly referred to PH clinics who underwent right heart catheterization (RHC) within 6 weeks and TTE within 60 days of enrolment (blinded central TTE reading) were classified by TTE probability of PH applying (i) the 2015 European Society of Cardiology (ESC)/European Respiratory Society (ERS) TTE algorithm or (ii) right ventricular systolic pressure (RVSP) > 40 mmHg.
Right ventricular (RV) function assessment using catheter-derived pressure-volume (PV) loops is used in translational research, providing detailed insights into cardiac mechanics. Its practical implementation requires methodological accuracy to ensure rigor, reproducibility and transparency.
Watch this Living Legends in PH webinar recording as Stuart Rich reflects on a career that helped define modern PH care. From leading the first NIH Registry on Primary Pulmonary Hypertension to advancing breakthrough treatments, this session explores the scientific milestones, clinical insights, and personal reflections behind decades of progress in PH.
